W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Education and outreach to Congressional staff on coverage and reimbursement of drugs in the Republic of Korea. P.L. 112-41, The United States-Korea Free Trade Agreement Implementation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to regulatory pathway for biosimilars and orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
H.R. 3630/H.R. 3765: Temporary Payroll Tax Cut Continuation Act of 2011 as they related to Medicare reimbursement for Part B drugs. P.L. 112-25 - The Budget Control Act of 2011 as it relates to Medicare reimbursement for Part B drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.